Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.80
Delayed Data
As of Sep 26
 -0.03 / -0.78%
Today’s Change
2.96
Today|||52-Week Range
18.62
-75.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
AssetsCash66.8M72.1M63.0M32.5M
 
 
 
 
 
Short Term Investment Cash-14.8M5.3M-9.1M-30.5M
 
 
 
 
 
Cash & Short Term Investments303.4M289.9M254.0M220.1M
 
 
 
 
 
 
ReceivablesReceivables1.7M970.0K847.0K1.1M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.1M4.1M6.1M7.5M
 
 
 
 
 
Current Assets309.3M294.9M261.0M228.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross11.9M28.5M----
 
 
 
Depreciation---17.1M----
 
 
Intangible Assets30.0M29.8M29.5M29.3M
 
 
 
 
 
Other Assets31.5M31.2M29.6M31.1M
 
 
 
 
 
Total Assets352.6M337.6M301.9M271.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.2M1.5M2.6M706.0K
 
 
 
 
 
Accrued Expenses19.6M18.7M18.4M14.9M
 
 
 
 
 
Other Current Liabilities22.4M23.1M22.7M19.3M
 
 
 
 
 
Other Liabilities23.6M30.2M25.3M20.0M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities10.4M17.2M16.6M16.5M
 
 
 
 
 
Total Liabilities34.0M47.5M41.9M36.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity318.6M290.1M260.0M234.7M
 
 
 
 
 
Total Shareholder Equity318.6M290.1M260.0M234.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding98.6M98.7M98.7M99.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.